JQ1-TCO
JQ1-TCO is the double bond E configuration of JQ1-TCO (HY-148864A) . JQ1-TCO (JQ1-trans-cyclooctene) is a derivative of JQ1 (HY-13030), an inhibitor of BET. JQ1-TCO is suitable for click chemistry and can be used as molecular probes in vitro and in vivo[1][2].
Product Specifications
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jq1-tco.html
Purity
99.95
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=C(C)SC2=C1C(C3=CC=C(C=C3)Cl)=N[C@@H](CC(NCCCNC(OC4CC/C=C/CCC4)=O)=O)C5=NN=C(C)N25
Molecular Formula
C31H37ClN6O3S
Molecular Weight
609.18
References & Citations
[1]Hu Z, et al. Recent Developments in PROTAC-Mediated Protein Degradation: From Bench to Clinic. Chembiochem. 2022 Jan 19;23 (2) :e202100270. |[2]Tyler DS, et al. Click chemistry enables preclinical evaluation of targeted epigenetic therapies. Science. 2017 Jun 30;356 (6345) :1397-1401.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD4
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
M2352-03Y-Biotin 100 µL
MAP Kinase 14 (Mitogen-activated Protein Kinase 14, MAPK 14, MAPK14, Mitogen-activated Protein Kinase p38alpha, MAP Kinase p38alpha, Cytokine Suppressive Anti-inflammatory Drug Binding Protein, CSAID Binding Protein, CSBP, MAX-interacting Protein 2, MAP Kinase MXI2, SAPK2A) (Biotin)
Sign In for Pricing
View Details 